Atsena Therapeutics

Durham, NC · Founded 2019 · Privately Held (backing)

Developer of ocular gene therapies designed to reverse or prevent blindness. Atsena Therapeutics is based in Durham, NC and was founded in 2019. It was valued at $340 million at its later-stage round in Apr 2025, the last priced event on record. It has raised $238 million across 4 recorded rounds; the latest was a $90 million later-stage round in Mar 2025.

PMV mark · valuation
$340.0M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$237.7M
Last round
Later Stage VC
Mar 2025

Who backs Atsena Therapeutics?

12 investors
InvestorType
Wellington ManagementAsset manager
Bain CapitalPE / buyout
Osage University PartnersVenture capital
Hatteras Venture PartnersVenture capital
Lightstone VenturesVenture capital
University of Florida Investment Corporation—
Abingworth—
Foundation Fighting Blindness-National Neurovision Research Institute—
Manning Family Foundation—
PBM Capital—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Atsena Therapeutics investors

12 investors are on record for Atsena Therapeutics, including Wellington Management, Bain Capital, Osage University Partners and Hatteras Venture Partners. By type, the record holds 3 venture capital firms, 1 asset manager and 1 private equity firm. The later-stage round in Mar 2025 drew 14 investors.

Free account
More of Atsena Therapeutics with a free account
  • ·The complete investor list: 12 names
  • ·Watch Atsena Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Atsena Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View